Title
Category
Credits
Event date
Cost
  • Advanced Practice Provider
  • 1.00 Participation
$0.00
Psycho-oncology or psychosocial oncology is a sub-specialty of oncology that addresses the psychological, behavioral, emotional, and social issues that arise for cancer patients and their families. A cancer diagnosis, the treatments that follow, and the adverse effects of cancer treatments are all very distressing for patients. Psycho-oncology includes providers from various disciplines that work together as a team to best support the complex needs people face when struggling with cancer.
  • Patient Centered Care
  • 1.00 Participation
$0.00
Cancer and cancer treatments can affect patient’s memory, concentration, and other aspects of cognition. While this condition is often called ‘chemo-brain,’ cognitive dysfunction can be due to many factors in patients with cancer. Dr. Nakamura will review our latest understandings of this condition.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit
  • 1.50 ASRT
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Noelle Robertson, MD, CAQSM presents an evidence-based review of outpatient primary care screening for breast, colon, lung and prostate cancer.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit
  • 1.50 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
In this webinar, Jared Lowe, MD, HMDC dicusses serious illness and discuss strategies to support patients with a primary focus on reviewing the services of palliative care and hospice care.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
William Wood, MD, MPH will review ways to expand traditional clinic-based cancer navigation to population-based cancer navigation using a central navigation approach. We will discuss how this approach can foster equity in care delivery and outcomes, while incorporating new initiatives that promote quality improvement. We will also talk about how this work fits into the current national environment that surrounds cancer navigation, including the recent development of a learning community and of new proposed billing codes that support the delivery of navigation services.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Symptom burden is high in thoracic surgery and oncology patients. Gita Mody, MD, MPH discusses the role of electronic patient-reported outcome (ePRO) remote monitoring systems to improve patients' survivorship care.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Sonali Acharya, PharmD. will explain the role of specialty pharmacies. We will discuss accreditation requirements for specialty pharmacies, process to determine which medications are considered specialty and specifically the benefits of a healthcare system specialty pharmacy.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Lauren Lux, MSW and Melissa Matson, MSN, RN, AGPCNP-BC and Catharine Swift, MSW, LCSW highlight tools and strategies that healthcare providers can deploy to meet the medical and psychosocial needs of the AYAs in their care.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Dr. Nakamura will present on key topics related to cognitive issues experienced by patients with cancer.
  • Patient Centered Care
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Tech
  • 1.00 ASRT
  • 1.00 CTR
  • 1.00 NCPD/CNE
  • 1.00 Participation
$0.00
Cancer patients and survivors have higher rates of anxiety and depression compared to the general population. Cancer-related anxiety and depression may significantly reduce wellbeing and result in adverse treatment and survival outcomes. This lecture will provide an overview of psychotherapeutic modalities that can treat cancer-related distress.

Pages